Invention Grant
- Patent Title: Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
-
Application No.: US14685091Application Date: 2015-04-13
-
Publication No.: US09279126B2Publication Date: 2016-03-08
- Inventor: Giovanni Monteleone
- Applicant: Nogra Pharma Limited
- Applicant Address: IE Dublin
- Assignee: Nogra Pharma Limited
- Current Assignee: Nogra Pharma Limited
- Current Assignee Address: IE Dublin
- Agency: Goodwin Procter LLP
- Priority: ITRM2003A0149 20030402
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/113 ; A61K38/00 ; A61K48/00

Abstract:
The invention relates to antisense oligonucleotidic sequences (ODN) against Smad7 suitably modified, and their uses in medical field as therapeutic biological agents, in particular in the treatment of chronic inflammatory bowel disease, such as Crohn's disease and ulcerative colitis.
Public/Granted literature
- US20150211011A1 Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical Field Public/Granted day:2015-07-30
Information query